Chamindie Punyadeera is a globally acknowledged pioneer in salivary diagnostics. She leads a world-class saliva research laboratory at the Queensland University of Technology in Australia, focusing on developing non-invasive diagnostic tools to detect early heart disease and head and neck cancers, linking oral health to systemic diseases.
Earlier in her hybrid career, Chamindie worked at Philips Electronics in the Netherlands where she was instrumental in developing the Philips Mini-care I-20 for cardiac disease detection. She maintains her links with industry as a consultant to Oasis Diagnostics®, USA and FLUIDS iQ™, Montreal, Canada.
A/Prof. Punyadeera has also produced 13 PCT applications and has licensed the salivary test for oral cancer to MDxHealth (USA). Her team is also developing prognostic assays using circulating tumour cells, and has partnered with Clearbridge Biomedics in translating this prognostic assay into clinical practice. In 2016 she convened the inaugural Australasian saliva conference.
Chamindie Punyadeera appears with thanks to Academic Partner QUT